DMCC Speciality Chemicals Limited (DMCC.BO)
INR 414.3
(-2.93%)
INR 414.3
(-2.93%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 249.98 Million | 298.8 Million | 511.32 Million | 322.45 Million | 269.95 Million | 208.51 Million |
| Net Income | 115.89 Million | 105.95 Million | 341.42 Million | 340.42 Million | 258.52 Million | 472.24 Million |
| Depreciation & Amortization | 157.12 Million | 176.05 Million | 80.59 Million | 68.29 Million | 61.64 Million | 45.13 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 20.72 Million | -76.69 Million | 109.04 Million | -72.54 Million | -22 Million | -237.4 Million |
| Other non-cash items | 294.85 Million | 93.48 Million | -19.74 Million | -13.72 Million | -28.19 Million | -71.45 Million |
| Investing Cash Flow | -104.52 Million | -205.59 Million | -982.8 Million | -396.61 Million | -168.4 Million | -126.93 Million |
| Investments in PPE | -189.41 Million | -219.06 Million | -986.04 Million | -473.14 Million | -169.61 Million | -137.96 Million |
| Acquisitions | 283 Thousand | 11.93 Million | - | 49.4 Million | - | - |
| Investment purchases | -15 Thousand | - | - | 3.44 Million | - | - |
| Sales/Maturities of investments | 84.62 Million | 9.86 Million | 414 Thousand | 23.68 Million | - | 8.66 Million |
| Other Investing Activities | 89 Million | 1.53 Million | 2.82 Million | 1000.00 | 1.21 Million | 2.36 Million |
| Financing Cash Flow | -133.14 Million | -99.93 Million | 454.82 Million | 30.22 Million | -56.55 Million | -81.3 Million |
| Debt repayment | -133.05 Million | -41.25 Million | -508.99 Million | -92.48 Million | -17.08 Million | -44.14 Million |
| Dividends payments | - | -24.94 Million | -12.47 Million | -38.05 Million | -29.41 Million | -30.01 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -99 Thousand | -33.74 Million | 976.28 Million | 160.76 Million | -10.05 Million | -7.14 Million |
| Accounts receivables | 61.63 Million | -55.16 Million | -181.5 Million | -80.55 Million | 49.24 Million | -79.05 Million |
| Accounts payables | -173.55 Million | 119.59 Million | 411.03 Million | 123.28 Million | -79.16 Million | -78.87 Million |
| Inventory | 87.57 Million | -108.48 Million | -46.67 Million | -96.4 Million | -27.3 Million | -42.43 Million |
| Other working capital | 45.07 Million | -32.62 Million | -73.8 Million | -18.86 Million | 35.22 Million | -37.04 Million |
| Cash at beginning of period | 24.35 Million | 22.54 Million | 39.2 Million | 83.14 Million | 38.15 Million | 37.87 Million |
| Cash at end of period | 36.76 Million | 15.82 Million | 22.54 Million | 39.2 Million | 83.15 Million | 38.14 Million |
| Capital Expenditure | -189.41 Million | -219.06 Million | -986.04 Million | -473.14 Million | -169.61 Million | -137.96 Million |
| Effect of forex changes on cash | - | - | -2000.00 | - | 1000.00 | -1000.00 |
| Net cash flow / Change in cash | 12.41 Million | -6.72 Million | -16.66 Million | -43.94 Million | 45 Million | 272 Thousand |
| Free Cash Flow | 60.57 Million | 79.74 Million | -474.71 Million | -150.69 Million | 100.34 Million | 70.54 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 115.89 Million | 57.73 Million | 3.07 Million | 23.71 Million | 31.36 Million | 105.95 Million |
| Depreciation & Amortization | 157.12 Million | - | 39.16 Million | 39.03 Million | 35.61 Million | 176.05 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 20.72 Million | - | - | - | - | -76.69 Million |
| Other non-cash items | 294.85 Million | -57.73 Million | -3.07 Million | -23.71 Million | -31.36 Million | 93.48 Million |
| Investing Cash Flow | -104.52 Million | - | - | - | - | -205.59 Million |
| Investments in PPE | -189.41 Million | - | - | - | - | -219.06 Million |
| Acquisitions | 283 Thousand | - | - | - | - | 11.93 Million |
| Investment purchases | -15 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | 84.62 Million | - | - | - | - | 9.86 Million |
| Other Investing Activities | 89 Million | - | - | - | - | 1.53 Million |
| Financing Cash Flow | -133.14 Million | - | - | - | - | -99.93 Million |
| Debt repayment | -133.05 Million | - | - | - | - | -41.25 Million |
| Dividends payments | - | - | - | - | - | -24.94 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -99 Thousand | - | - | - | - | -33.74 Million |
| Accounts receivables | 61.63 Million | - | - | - | - | -55.16 Million |
| Accounts payables | -173.55 Million | - | - | - | - | 119.59 Million |
| Inventory | 87.57 Million | - | - | - | - | -108.48 Million |
| Other working capital | 45.07 Million | - | - | - | - | -32.62 Million |
| Cash at beginning of period | 24.35 Million | - | 21.2 Million | -2.51 Million | 24.35 Million | 22.54 Million |
| Cash at end of period | 36.76 Million | - | 3.07 Million | 21.2 Million | 31.36 Million | 15.82 Million |
| Capital Expenditure | -189.41 Million | - | - | - | - | -219.06 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 12.41 Million | - | -18.12 Million | 23.71 Million | 7.01 Million | -6.72 Million |
| Free Cash Flow | 60.57 Million | - | 3.07 Million | 23.71 Million | 31.36 Million | 79.74 Million |
TIPSFILMS
MANG
ARTEMISMED
TM
AMRT
ALLGO